The limited data available suggest that pathways into drug-related treatment and the types of treatment vary between regionsData from 61 countries suggest that pathways of referral vary by (sub)region: for example, in Africa, referral by friends and family or self-referral is most common, while in…
Global availability, coverage and accessibility of drug-related treatment varies across intervention types.Not all types of pharmacological treatment, psychosocial interventions and rehabilitation and aftercare are available in all countries. Opioid agonist maintenance therapy and opioid antagonist…
Data on specific population groups remain limited.The available information suggests higher levels of drug use, drug use disorders and injecting drug use among sex workers, people experiencing homelessness and those with severe mental illness compared with the general population, while these tend…
Men continue to make up the majority of people who use drugs, but gender differences vary by drug and region.In 2024, about three quarters of people who used drugs in the past year were men, though the share of women varies substantially by region and drug type. For example, only 8 per cent of…
Data show a persistent reliance on the 3,4-MDP-2-P chemical pathway, an increased importance of pre-precursors related to 3,4-MDP-2-P methyl glycidic acid among “ecstasy” precursors, and an ongoing concentration of “ecstasy” precursor seizures in Europe.Historically, 3,4-MDP-2-P, also known as…
“Ecstasy” seizures reached record levels in 2024, surpassing pre-COVID-19 pandemic highs.The quantity of “ecstasy” (MDMA) seized worldwide increased by 13 percent from 2023 to 2024, more than doubling compared with 2021 levels, following a pandemic-related decline.Increases were widespread in 2024…
Most “ecstasy” found in the global market continues to be produced in the subregion of Western and Central Europe.Data suggest that the bulk of the "ecstasy" is still being produced in Europe, with 82 per cent of reported countries of transit or departure of seized shipments around the world being…
“Ecstasy” use remains highest in high income countries and parts of Asia.Past-year use of "ecstasy" globally is estimated at 0.4 per cent among those aged 15-64. Use is higher among men (0.54 per cent) than women (0.26 per cent), but the difference is not as pronounced as for other drugs (for…
Australia and New Zealand have the highest global annual prevalence of use of "ecstasy", where it is mostly used in capsule and crystal form.In Australia, the use and availability of "ecstasy" declined during the COVID-19 pandemic but have started to increase again in 2023 (while not yet reaching…
“Ecstasy” use remains concentrated in Europe (mainly Western and Central Europe)Use is significantly higher in Western and Central Europe than in Eastern and South-Eastern Europe, both in terms of prevalence (1.2 per cent vs. 0.4 per cent) and number of users (nearly 4 million versus less than 800,…
Cannabis dominates the global number of seizure cases, followed by ATS (notably methamphetamine) and cocaine while cannabis and cocaine dominate seizures in terms of total weight.
Drug-related deaths continue to rise globally, with indirect causes accounting for most harm.The total global number of deaths directly or indirectly attributable to drugs continued to increase in 2023, although population-adjusted rates have grown more slowly, suggesting that the growth was in…
